Skip to content

inhaled human insulin

DRUG18 trials

Sponsors

Pfizer, Novo Nordisk A/S, Dance Biopharm Inc.

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseDiabetesDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Safety and TolerabilityType 2 Diabetes Mellitus

Phase 1

Phase 2

Phase 3

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
TerminatedNCT00287066
PfizerDiabetes Mellitus
Start: 2006-02-28End: 2007-03-31Target: 22Updated: 2008-02-21
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
TerminatedNCT00322257
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1
Start: 2006-05-01End: 2008-04-02Updated: 2018-09-05
Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
TerminatedNCT00331604
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2
Start: 2006-08-31End: 2008-05-05Updated: 2017-03-01
Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
TerminatedNCT00343980
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2
Start: 2006-10-10End: 2008-03-10Updated: 2017-03-01
Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
TerminatedNCT00348712
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2
Start: 2006-10-30End: 2008-03-05Updated: 2017-03-01
Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.
CompletedNCT00370565
PfizerDiabetes Mellitus, Type 2
Start: 1999-06-30End: 2000-09-30Target: 345Updated: 2007-02-13
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
TerminatedNCT00411892
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2
Start: 2006-11-29End: 2008-03-18Updated: 2018-09-05
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
CompletedNCT00424437
PfizerDiabetes Mellitus, Type 1
Start: 1999-09-30End: 2000-09-30Target: 320Updated: 2007-02-13
Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes
CompletedNCT00424333
PfizerDiabetes Mellitus, Type 1
Start: 1999-05-31End: 2000-10-31Target: 320Updated: 2007-02-13
Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes
TerminatedNCT00427154
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2
Start: 2007-01-10End: 2008-03-11Updated: 2018-09-05
Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes
TerminatedNCT00469586
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2
Start: 2007-04-26End: 2008-04-24Updated: 2017-03-01
Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
TerminatedNCT00472953
Novo Nordisk A/SChronic Obstructive Pulmonary Disease, Diabetes, Diabetes Mellitus, Type 1 +1
Start: 2007-05-15End: 2008-03-05Updated: 2017-03-01
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
TerminatedNCT00523042
Novo Nordisk A/SAsthma, Diabetes, Diabetes Mellitus, Type 1 +1
Start: 2007-08-30End: 2008-02-28Updated: 2018-09-05
Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
CompletedNCT00725036
Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1
Start: 2002-09-02End: 2004-12-14Updated: 2017-03-01

Related Papers